ArticleThe Journal of clinical investigation2025

TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment.

Pu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.